BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

260 related articles for article (PubMed ID: 20921280)

  • 1. Fluorodesoxyglucose uptake in the remaining adrenal glands during the follow-up of patients with adrenocortical carcinoma: do not consider it as malignancy.
    Leboulleux S; Deandreis D; Escourrou C; Al Ghuzlan A; Bidault F; Aupérin A; Travagli JP; Lumbroso J; Schlumberger M; Baudin E
    Eur J Endocrinol; 2011 Jan; 164(1):89-94. PubMed ID: 20921280
    [TBL] [Abstract][Full Text] [Related]  

  • 2. High (18)F-FDG uptake by the remaining adrenal gland four months after surgery and initiation of mitotane treatment in two patients with adrenocortical carcinoma.
    Mpanaka I; Lyra VD; Kaltsas G; Chatziioannou SN
    Hell J Nucl Med; 2011; 14(2):168-72. PubMed ID: 21761022
    [TBL] [Abstract][Full Text] [Related]  

  • 3. 18F-FDG PET/CT in the post-operative monitoring of patients with adrenocortical carcinoma.
    Ardito A; Massaglia C; Pelosi E; Zaggia B; Basile V; Brambilla R; Vigna-Taglianti F; Duregon E; Arena V; Perotti P; Penna D; Terzolo M
    Eur J Endocrinol; 2015 Dec; 173(6):749-56. PubMed ID: 26346137
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Predicitve Value of FDG Uptake in the Remaining Adrenal Gland Following Adrenalectomy for Adrenocortical Cancer.
    Loewe R; Rogowski-Lehmann N; Pfluger T; Reincke M; Hahner S; Bluemel C; Fassnacht M; Beuschlein F
    Horm Metab Res; 2021 Jan; 53(1):24-31. PubMed ID: 33086388
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Preoperative 18F-FDG uptake is strongly correlated with malignancy, Weiss score, and molecular markers of aggressiveness in adrenal cortical tumors.
    Gust L; Taieb D; Beliard A; Barlier A; Morange I; de Micco C; Henry JF; Sebag F
    World J Surg; 2012 Jun; 36(6):1406-10. PubMed ID: 22131094
    [TBL] [Abstract][Full Text] [Related]  

  • 6. 18F-FDG PET reveals an adrenocortical carcinoma in a bilateral adrenal multinodular disease.
    Libé R; Jazeron JF; Louiset E; Groussin L
    Endocrine; 2019 Jan; 63(1):188-189. PubMed ID: 30251165
    [No Abstract]   [Full Text] [Related]  

  • 7. Assessment of tumor heterogeneity in treatment-naïve adrenocortical cancer patients using (18)F-FDG positron emission tomography.
    Werner RA; Kroiss M; Nakajo M; Mügge DO; Hahner S; Fassnacht M; Schirbel A; Bluemel C; Higuchi T; Papp L; Zsótér N; Buck AK; Bundschuh RA; Lapa C
    Endocrine; 2016 Sep; 53(3):791-800. PubMed ID: 27138903
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Quantitative analysis of normal and pathologic adrenal glands with 18F-FDOPA PET/CT: focus on pheochromocytomas.
    Moreau A; Giraudet AL; Kryza D; Borson-Chazot F; Bournaud C; Mognetti T; Lifante JC; Combemale P; Giammarile F; Houzard C
    Nucl Med Commun; 2017 Sep; 38(9):771-779. PubMed ID: 28704339
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Use of 18F-FDG-positron emission tomography in presurgical evaluation of nonspecific or suspectious adrenal masses in non-oncologic patients].
    Pavón-Paz I; Rosado-Sierra JA; Balsa-Bretón MÁ; Guijarro-Armas G; Merino-Viveros M; Penín-Gonzalez FJ
    Med Clin (Barc); 2016 Feb; 146(3):104-7. PubMed ID: 26343158
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Characterization of adrenocortical tumors by
    Paladino NC; Guérin C; Lowery A; Attard A; Essamet W; Slotema E; Morange I; Castinetti F; Brue T; Loundou A; Taïeb D; Sebag F
    Surg Oncol; 2018 Jun; 27(2):231-235. PubMed ID: 29937176
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Recurrent adrenocortical carcinoma after laparoscopic resection.
    Schlamp A; Hallfeldt K; Mueller-Lisse U; Pfluger T; Reincke M
    Nat Clin Pract Endocrinol Metab; 2007 Feb; 3(2):191-5; quiz 1 p following 195. PubMed ID: 17237845
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Functioning metastasis from adrenocortical carcinoma.
    Cunha C; Donato S; Silva T; Leite V
    BMJ Case Rep; 2022 Jan; 15(1):. PubMed ID: 35078872
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Therapy of the adrenocortical carcinoma with Lysodren (o,p'-DDD). Therapeutic management by monitoring o,p'-DDD blood levels].
    Heilmann P; Wagner P; Nawroth PP; Ziegler R
    Med Klin (Munich); 2001 Jul; 96(7):371-7. PubMed ID: 11494911
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A concomitant false-negative ¹⁸F-FDG PET imaging in an adrenocortical carcinoma and a high uptake in a corresponding liver metastasis.
    Ghander C; Tissier F; Tenenbaum F; Silvera S; Ragazzon B; Bertherat J; Bertagna X; Dousset B; Richard B; Legmann P; Groussin L
    J Clin Endocrinol Metab; 2012 Apr; 97(4):1096-7. PubMed ID: 22319030
    [No Abstract]   [Full Text] [Related]  

  • 15. FDG-PET in adrenocortical carcinoma.
    Becherer A; Vierhapper H; Pötzi C; Karanikas G; Kurtaran A; Schmaljohann J; Staudenherz A; Dudczak R; Kletter K
    Cancer Biother Radiopharm; 2001 Aug; 16(4):289-95. PubMed ID: 11602999
    [TBL] [Abstract][Full Text] [Related]  

  • 16. 18F-FDG PET for the identification of adrenocortical carcinomas among indeterminate adrenal tumors at computed tomography scanning.
    Nunes ML; Rault A; Teynie J; Valli N; Guyot M; Gaye D; Belleannee G; Tabarin A
    World J Surg; 2010 Jul; 34(7):1506-10. PubMed ID: 20396886
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Adrenocortical Carcinoma Treated by CyberKnife.
    Harada Y; Miyazaki S
    Intern Med; 2016; 55(15):2031-4. PubMed ID: 27477410
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Non-androgen secreting adrenocortical carcinoma in preadolescence: a case report and literature review.
    Narumi H; Hasegawa S; Waki K; Fukuda K; Ohnishi Y; Ichimura T; Fujimoto Y; Katsura S; Kawano H; Ikeda E; Okada S; Ohga S
    J Pediatr Endocrinol Metab; 2016 Nov; 29(11):1313-1317. PubMed ID: 27771624
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Positive Correlation Between 18 F-FDG Uptake and Tumor-Proliferating Antigen Ki-67 Expression in Adrenocortical Carcinomas.
    Libé R; Pais A; Violon F; Guignat L; Bonnet F; Huillard O; Assié G; Gaillard M; Dousset B; Gaujoux S; Barat M; Dohan A; Sibony M; Bertherat J; Cottereau AS; Tenenbaum F; Coste J; Groussin L
    Clin Nucl Med; 2023 May; 48(5):381-386. PubMed ID: 36758555
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The computed tomography adrenal wash-out analysis properly classifies cortisol secreting adrenocortical adenomas.
    Humbert AL; Lecoanet G; Moog S; Bouderraoui F; Bresler L; Vignaud JM; Chevalier E; Brunaud L; Klein M; Cuny T
    Endocrine; 2018 Mar; 59(3):529-537. PubMed ID: 29332161
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.